Full Health Medical, a Dublin-headquartered medtech company, raised €3m (about $3.5m) in a funding round led by Elkstone, Silicon Republic reported on 1 September 2026. Enterprise Ireland and unnamed strategic angel investors also took part.
The company did not disclose a valuation. Silicon Republic did not give a stage for the round, and Dealroom described it as early-stage.
Full Health Medical said the money would fund expansion into markets outside Ireland and the UK, where it already operates, as well as the completion of its next-generation platform and work towards medical device certification. The company told Silicon Republic it was looking at opportunities in the Middle East and Australia.
“We need a cultural shift towards prevention. We can only make a meaningful change by equipping individuals with the tools to understand their own health data.”Dr Ann Shortt, Co-Founder, Full Health Medical
What Full Health Medical does
Founded in 2011, Full Health Medical runs the logistics of health screening programmes and automates the clinical interpretation of the results using algorithms written by consultant doctors, according to the company. It says every output is auditable and clinically governed.
The company says the approach reduces the time doctors spend reviewing results by hand, and that the platform produces health reports in plain language so that patients can understand their results. Its platform has processed more than 500,000 medical screenings in Ireland and the UK.
Customers include Medmark, an occupational health services provider. Elkstone said the client base also includes some of Ireland's largest population health programmes, without naming them. The company did not say how many programmes or employers use the platform.
Who runs the company
Full Health Medical was founded by Dr Ann Shortt, an emergency medicine consultant, and Paul McCarthy. It is led by chief executive Dermot Shortt, a co-founder of Finbourne Technology, with Rizwan Saeed as chief technology officer.
Ann Shortt said her years in emergency medicine had shown her the growing pressure on health systems from rising demand, limited resources and delayed intervention. "We need a cultural shift towards prevention," she said.
Dermot Shortt said wearables, home test kits and similar tools had improved people's understanding of their health data, but that the best standard of care was still a clinician who can combine a patient's history and a physical examination with laboratory results. The company's pitch is that its consultant-written algorithms let that kind of clinical judgement be applied to screening programmes covering large numbers of people.
Dermot Shortt said the main obstacle to wider screening was cost, because a clinician cannot be scaled across large populations without raising expenses. "We solve that problem," he said.
Who invested
Elkstone led the round. Its co-founder Alan Merriman said Full Health Medical was addressing a bottleneck in healthcare: the clinical expertise needed to interpret health data safely and at scale. He pointed to the half a million medicals processed so far and to what he called emerging international traction.
Enterprise Ireland also invested, alongside strategic angel investors who were not named.
Neither Silicon Republic nor Dealroom reported earlier funding rounds or a total raised to date, and the company did not give a headcount.
Company website: fullhealthmedical.com